Physician profile
Navid Zaer
NPI 1811150386
$4,089.12
in general payments reported to CMS, 2019-2025
37 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 86% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $167 · 2021: $120 · 2022: $772 · 2023: $860 · 2024: $877 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,821.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $481.30 | 2022-2025 | Enhertu, Imfinzi, Tagrisso |
| Stryker Corporation | $373.02 | 2025 | Flowtriever, Optablate, Clottriever Bold Catheter |
| Merck Sharp & Dohme LLC | $360.50 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $359.57 | 2020-2025 | |
| Inari Medical, INC. | $303.19 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Seagen INC. | $276.88 | 2020-2023 | Padcev |
| Exelixis INC. | $238.61 | 2022-2023 | Cabometyx |
| Eisai INC. | $218.46 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $146.38 | 2019-2023 | Opdivo |
| Incyte Corporation | $136.37 | 2019-2023 | Jakafi |
| Medtronic, INC. | $106.69 | 2025 | Kyphon Express II Kyphopak Tray |
| Gilead Sciences, INC. | $87.40 | 2022-2024 | Trodelvy |
| Pharmacyclics LLC, An Abbvie Company | $79.75 | 2019-2023 | Imbruvica |
| Janssen Biotech, INC. | $68.07 | 2025 | Erleada, Rybrevant |
| Mirati Therapeutics, INC. | $63.72 | 2024 | Krazati |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geron Corporation | $61.12 | 2024-2025 | Rytelo |
| Takeda Pharmaceuticals U.S.A., INC. | $59.97 | 2021-2023 | Fruzaqla |
| Boston Scientific Corporation | $59.74 | 2020-2023 | |
| Sobi, INC | $57.94 | 2024-2025 | |
| Penumbra, INC. | $57.68 | 2023 | Indigo System, Ruby Coil |
| Beigene USA, INC. | $57.14 | 2024 | Brukinsa |
| Abbvie INC. | $54.57 | 2024-2025 | |
| Amgen INC. | $49.80 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $33.64 | 2024 | Libtayo |
| Blue Earth Diagnostics | $32.96 | 2025 | Posluma |
| Bard Peripheral Vascular, INC. | $28.15 | 2024 | Trek |
| Sirtex Medical INC | $26.91 | 2024 | Lava Les (Liquid Embolic System) |
| Z-Medica, LLC | $26.26 | 2020 | |
| Servier Pharmaceuticals LLC | $24.98 | 2025 | |
| Terumo Medical Corporation | $24.39 | 2024 | Angio-Seal |
| Myovant Sciences INC. | $24.09 | 2022 | |
| Celgene Corporation | $22.82 | 2019 | |
| Cordis US Corp. | $21.57 | 2023 | Mynx Control |
| Lilly USA, LLC | $17.08 | 2019 | |
| Trisalus Life Sciences, INC. | $16.68 | 2025 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $16.42 | 2022 | |
| Cardinal Health 200 LLC | $15.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Zaer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.